Replies to post #90090 on DD Support Board and Research Team

[DragonBear]

Thanks. From what I read last night

evidently Namenda doesn't work all that well for most people either.

Whether the drugs work or not is dependent on the physiological damage already done, and underway. For ALZ you have such things as the plaque build up. For Dementia one can have tangles of nerve endings and cells due to un-noticed past mini-strokes. No neuro-transmitter enhancer is going to be able to overcome damage already in place. So a cocktail of drugs is given in the hope of getting undamaged neurons, and brain cells to take over the function of the cells damaged. I was going to say something else, but I can't remember what it was. LOL

The AXON drug bought from GSK is interesting in concept. But GSK couldn't demonstrate it worked. Interesting was more than one trial was on populations in Eastern Europe. Easier to recruit? Less regulations?